Table I.
Authors | Population: primary OA vs. various† | Component | No. of participants | Total no. of shoulders with radiolucency at final follow-up | ASES score | Constant score | Revision rate |
---|---|---|---|---|---|---|---|
Arnold et al,5 2011 | Primary | Pegged | 35 | 11 | 81.3 | 0 | |
Bell and Coghlan,7 2014 | Primary | Pegged | 50 | 8 | 92.58 | 86 | 0.020 |
Budge et al,9 2013 | Various | Keeled | 19 | 1 | 70.5 | 0.158 | |
Collin et al,12 2011 | Primary | Keeled | 56 | 20 | 63 | 0.054 | |
De Wilde et al,14 2013 | Various | Pegged | 34 | 4 | 72 | ||
Denard et al,15 2013 | Primary | Keeled | 50 | 22 | 73.4 | 0.34 | |
Fox et al,19 2013 | Various | Keeled | 151 | 102 | 0.046 | ||
Gazielly and Scarlat,23 2015 | Primary | Keeled | 39 | 6 | 73 | 0.026 | |
Greiner et al,25 2013 | Various | Pegged | 90 | 24 | 84.2 | 0.075 | |
Groh,26 2010 | Various | Pegged | 83 | 0 | 0 | ||
Gulotta et al,27 2015 | Primary | Pegged | 40 | 80.1 | 0.05 | ||
Ho et al,28 2013 | Primary | Pegged | 66 | 29 | |||
Hsu et al,29 2014 | Unspecified | Pegged | 50 | 89.85 | 0.04 | ||
Kooistra et al,31 2017 | Primary | Keeled | 29 | 84 | 0 | ||
McLendon et al,35 2017 | Various | Pegged | 287 | 227 | 0.091 | ||
Merolla et al,36 2016 | Primary | Pegged | 40 | 2 | 93.4 | 69.8 | 0 |
Nuttall et al,39 2012 | Primary | Pegged | 11 | 6 | 85 | 63 | |
Nuttall et al,38 2017 | Primary | Pegged | 11 | 74.7 | 61.4 | ||
Press et al,42 2014 | Various | Pegged: perforated | 18 | 91 | 77.4 | ||
Pegged: unperforated | 34 | 82.6 | 75.6 | ||||
Service et al,45 2017 | Various | Pegged | 71 | 20 | 0.042 | ||
Vidil et al,49 2013 | Various | Pegged | 27 | 3 | 74.5 | 0 | |
Walch et al,51 2011 | Primary | Keeled | 302 | 57 | 67.6 | 0.026 | |
Walch et al,50 2012 | Primary | Keeled | 518 | 166 | |||
Wirth et al,53 2012 | Various | Pegged | 44 | 84.5 | 0.023 | ||
Young et al,54 2011 | Primary | Keeled | 217 | 99 | 57.6 | 0.168 |
OA, osteoarthritis; ASES, American Shoulder and Elbow Surgeons.
All values are presented at latest follow-up; number of participants are based on participants included in the radiolucency analysis.
Various includes inflammatory arthritis, post-traumatic arthritis, osteonecrosis, rheumatoid arthritis, and other.